Inventor · disambiguated record
Michel Goldman
Also filed as: GOLDMAN MICHEL
8 granted patents·9 pending applications·62 citations·filing 1998–2011
84Inventor score
Top patents by PatentIndex Score
17 records- 0183US6369065B1CD40 signal blocking agentUCB SA·Filed 2000·Granted Apr 9, 2002·35 cites·23 claims
- 0273US7405076B2Generation and use of dendritic cellsUNIV BRUXELLES·Filed 2001·Granted Jul 29, 2008·12 cites·10 claims
- 0365US8067172B2Device, kit and method for pulsing biological samples with an agent and stabilising the sample so pulsedSTORDEUR PATRICK·Filed 2010·Granted Nov 29, 2011·2 cites·57 claims
- 0461US7700276B2Device, kit and method for pulsing biological samples with an agent and stabilising the sample so pulsedUNIV BRUXELLES·Filed 2003·Granted Apr 20, 2010·6 cites·51 claims
- 0559US7947450B2Device, kit and method for pulsing biological samples with an agent and stabilising the sample so pulsedUNIV BRUXELLES·Filed 2008·Granted May 24, 2011·3 cites·15 claims
- 0658US8206916B2Device, kit and method for pulsing biological samples with an agent and stabilising the sample so pulsedSTORDEUR PATRICK·Filed 2011·Granted Jun 26, 2012·1 cites·22 claims
- 0756US2009081127A1Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor responseMOSER MURIEL·Filed 2008·Application pending·0 cites
- 0847US2010069312A1Aminoalkyl glucosamine phosphate compounds for treating autoimmune diseasesUNIV BRUXELLES·Filed 2008·Application pending·0 cites
- 0947US2003118562A1Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor responseFiled 2002·Application pending·0 cites
- 1047US2003031656A1Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor responseFiled 2002·Application pending·0 cites
- 1146US2002141973A1Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor responseFiled 2001·Application pending·0 cites
- 1245US2005042751A1Generation and use of new types of dendritic cellsFiled 2002·Application pending·0 cites
- 1344US8426170B2Method for evaluating the response of an individual to a treatment with a type I interferon (IFN)STORDEUR PATRICK·Filed 2008·Granted Apr 23, 2013·0 cites·7 claims
- 1444US2005153292A1Method to determine in vivo nucleic acid levelsFiled 2003·Application pending·0 cites
- 1543US2001012632A1Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor responseFiled 2001·Application pending·0 cites
- 1626US6407081B1Method for inhibiting cytokine production by cellsPREVISAN AG·Filed 1998·Granted Jun 18, 2002·3 cites·13 claims
- 1726US2012190031A1Marker for diagnosis of active multiple sclerosisSTORDEUR PATRICK·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michel Goldman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →